| Type | Valeur |
|---|---|
| cik | 0001281761 |
| ticker | RF |
Achats discrétionnaires moins ventes en USD par fenêtre roulante. Hors compensation.
| Date | Type | Insider | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 11 mai 2026 | GRANT_AWARD | Crosswhite Mark A. | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | Davis Noopur | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | Golodryga Zhanna | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | Hill J Thomasentité | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | JOHNSON JOIA M | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | Jenkins Roger W. | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | MARSHALL RUTH ANN | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | RHODES WILLIAM C III | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | SUQUET JOSE Sentité | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | STYSLINGER LEE J III | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | Rand Alison S. | 5 404 | 0.00 USD | deriv |
| 11 mai 2026 | GRANT_AWARD | VINES TIMOTHY | 5 404 | 0.00 USD | deriv |
| 06 mai 2026 | EXERCISE | RHODES WILLIAM C III | 7 904 | 0.00 USD | |
| 06 mai 2026 | EXERCISE | RHODES WILLIAM C III | 7 904 | 0.00 USD | deriv |
| 07 mai 2026 | SALE | Willman Brian R | 7 014 | 27.91 USD | |
| 06 mai 2026 | EXERCISE | Davis Noopur | 7 904 | 0.00 USD | |
| 06 mai 2026 | EXERCISE | Davis Noopur | 7 904 | 0.00 USD | deriv |
| 06 mai 2026 | EXERCISE | Golodryga Zhanna | 7 904 | 0.00 USD | |
| 06 mai 2026 | EXERCISE | Golodryga Zhanna | 7 904 | 0.00 USD | deriv |
| 06 mai 2026 | EXERCISE | JOHNSON JOIA M | 7 904 | 0.00 USD | |
| 06 mai 2026 | EXERCISE | JOHNSON JOIA M | 7 904 | 0.00 USD | deriv |
| 06 mai 2026 | EXERCISE | Jenkins Roger W. | 7 904 | 0.00 USD | |
| 06 mai 2026 | EXERCISE | Jenkins Roger W. | 7 904 | 0.00 USD | deriv |
| 06 mai 2026 | EXERCISE | PROKOPANKO JAMES T | 63 055 | 0.00 USD | |
| 06 mai 2026 | EXERCISE | PROKOPANKO JAMES T | 63 055 | 0.00 USD | deriv |